T1	Claim 534 569	Study of hormone receptors and HER2
T2	Premise 57 171	A 67-year-old woman diagnosed with infiltrating ductal carcinoma of the breast with no family history of neoplasia
T3	Claim 287 330	Complete phenotypic study by flow cytometry
T4	Claim 335 370	Study of hormone receptors and HER2
T5	Claim 375 449	Study of hormone receptors, e-cadherin and study of first-degree relatives
T6	Claim 454 507	Study of BRCA 1-2 and study of first-degree relatives
T7	Claim 571 765	Both for the type of treatment and to study the prognostic factor and adjuvant treatment, it is necessary to know the different hormonal receptors (estrogen and progesterone) as well as HER2-neu
R1	Support Ent1:T7 Ent2:T1	
R2	Support Ent1:T1 Ent2:T4	
T8	Diagnostics 287 330	Complete phenotypic study by flow cytometry
T9	Diagnostics 335 370	Study of hormone receptors and HER2
T10	Diagnostics 375 413	Study of hormone receptors, e-cadherin
T11	Diagnostics 418 449	study of first-degree relatives
T12	Diagnostics 454 471	Study of BRCA 1-2
T13	Diagnostics 476 507	study of first-degree relatives
